je.st
news
Biogen Inc (BIIB) Rating Increased to Strong-Buy at Vetr Inc.
2015-12-04 08:27:19| Biotech - Topix.net
The brokerage presently has a $315.11 price target on the biotechnology company's stock. Vetr 's price objective points to a potential upside of 14.38% from the stock's current price.
Tags: inc
rating
increased
biogen
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||